Effects of admission systemic inflammatory indicators on clinical outcomes in patients with vertebrobasilar artery occlusion: insight from the PERSIST registry

医学 内科学 白细胞 中性粒细胞与淋巴细胞比率 改良兰金量表 逻辑回归 闭塞 多元分析 心脏病学 淋巴细胞 缺血性中风 缺血
作者
Pan Zhang,Pengfei Xu,Zuowei Duan,Feng Zhang,Yirong Fang,Dingyi Yan,Hanhong Zhang,Qiankun Cai,Xianjun Huang,Zhixin Huang,Mengmeng Gu,Lulu Xiao,Jinjing Wang,Wen Sun
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:15 (e2): e270-e276 被引量:4
标识
DOI:10.1136/jnis-2022-019437
摘要

Few studies have focused on the effect of systemic inflammation in vertebrobasilar artery occlusion (VBAO). The aim of this study was to investigate the relationship between inflammatory indicators and the prognosis of VBAO patients receiving endovascular treatment (EVT).Patients with VBAO who were treated with EVT within 24 hours of the estimated occlusion time were included in this study. Multivariate logistic regression and elastic net regularization were performed to analyze the effects of inflammatory indicators on the prognosis of patients with VBAO. The primary outcome was unfavorable outcome (a modified Rankin Scale score of 4-6) at 90 days. Secondary outcomes included symptomatic intracranial hemorrhage, in-hospital mortality, 90 day mortality, 1 year unfavorable outcome, and mortality.560 patients were included in the study. Multivariate analysis showed that white blood cells (W), neutrophils (N), neutrophil to lymphocyte ratio (NLR), platelet to neutrophil ratio, platelet to white blood cell ratio, and NLR to platelet ratio were associated with the primary outcome. Elastic net regularization indicated that W, N, and NLR were the major inflammatory predictors of unfavorable outcome at 90 days. For long term prognosis, we found that the inflammatory indicators that predicted 1 year outcomes were consistent with those that predicted 90 day outcomes.Inflammatory indicators, especially W, N, and NLR, were associated with moderate and long term prognosis of patients with VBAO treated with EVT.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yzy发布了新的文献求助10
刚刚
从来都不会放弃zr完成签到,获得积分10
刚刚
点点发布了新的文献求助10
刚刚
科研通AI2S应助Feng采纳,获得10
刚刚
张小小完成签到,获得积分10
刚刚
hata发布了新的文献求助10
1秒前
1秒前
yangyangyang发布了新的文献求助10
1秒前
keran发布了新的文献求助10
1秒前
shin0324完成签到,获得积分10
2秒前
pencil123应助易达采纳,获得10
2秒前
守约完成签到,获得积分10
3秒前
4秒前
4秒前
愤怒的之玉完成签到 ,获得积分10
5秒前
5秒前
欧阳小枫完成签到,获得积分10
5秒前
江海下百川完成签到,获得积分10
5秒前
5秒前
JamesPei应助小宇采纳,获得10
6秒前
6秒前
阿桂完成签到,获得积分10
6秒前
6秒前
沙比完成签到,获得积分10
7秒前
一一完成签到,获得积分10
7秒前
MicroCytoYL完成签到,获得积分10
8秒前
8秒前
一只特立独行的朱完成签到,获得积分10
8秒前
步行街车神ahua完成签到,获得积分10
8秒前
8秒前
keran完成签到,获得积分20
8秒前
1111发布了新的文献求助10
8秒前
动如脱兔发布了新的文献求助10
9秒前
starry完成签到,获得积分10
9秒前
10秒前
Grayball应助愉快的冰珍采纳,获得10
10秒前
10秒前
11秒前
Pangsj发布了新的文献求助10
11秒前
11秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Social media impact on athlete mental health: #RealityCheck 1020
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3527304
求助须知:如何正确求助?哪些是违规求助? 3107454
关于积分的说明 9285518
捐赠科研通 2805269
什么是DOI,文献DOI怎么找? 1539827
邀请新用户注册赠送积分活动 716708
科研通“疑难数据库(出版商)”最低求助积分说明 709672